Prostate-specific antigen (PSA) is a protein secreted only by epithelial prostate cells, and its elevation in serum is used to detect prostate cancer in men.Elevated PSA levels are associated with prostatitis, inflammation of the prostate or benign forms of prostatic hyperplasia, making it a valuable tumor marker for prostate cancer.The use of serology-based biomarkers for the diagnosis of prostate cancer has stimulated the need for prostate-specific antigen (PSA).
This report contains market size and forecasts of Prostate-specific Antigen (PSA) Testing in Global, including the following market information:
Global Prostate-specific Antigen (PSA) Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate-specific Antigen (PSA) Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CLIA Method Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate-specific Antigen (PSA) Testing include Abbott, Boston Scientific Corporation, Bayer AG, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer and Tosoh, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate-specific Antigen (PSA) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate-specific Antigen (PSA) Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate-specific Antigen (PSA) Testing Market Segment Percentages, by Type, 2021 (%)
CLIA Method
ELISA Method
Global Prostate-specific Antigen (PSA) Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate-specific Antigen (PSA) Testing Market Segment Percentages, by Application, 2021 (%)
Screening
Post-treatment Monitoring
Other
Global Prostate-specific Antigen (PSA) Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate-specific Antigen (PSA) Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate-specific Antigen (PSA) Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate-specific Antigen (PSA) Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA